Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches

The application of modeling and simulation (M&S) tools to biological, physiological, and clinical data has great potential to enhance drug development and regulatory decision making. The strategic development of multidisciplinary projects aimed at integrating methodologies from different discipl...

Full description

Bibliographic Details
Main Authors: Stephan Schmidt, Sarah Kim, Valvanera Vozmediano, Rodrigo Cristofoletti, Almut G. Winterstein, Joshua D. Brown
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:CPT: Pharmacometrics & Systems Pharmacology
Online Access:https://doi.org/10.1002/psp4.12425
id doaj-a3e76b8ec38a470a9af082611e69b03f
record_format Article
spelling doaj-a3e76b8ec38a470a9af082611e69b03f2020-11-25T02:49:31ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062019-06-018635235510.1002/psp4.12425Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological ApproachesStephan Schmidt0Sarah Kim1Valvanera Vozmediano2Rodrigo Cristofoletti3Almut G. Winterstein4Joshua D. Brown5Center for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USACenter for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USACenter for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USACenter for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USACenter for Drug Evaluation and Safety Department of Pharmaceutical Outcomes and Policy College of Pharmacy University of Florida Gainesville Florida USACenter for Drug Evaluation and Safety Department of Pharmaceutical Outcomes and Policy College of Pharmacy University of Florida Gainesville Florida USAThe application of modeling and simulation (M&S) tools to biological, physiological, and clinical data has great potential to enhance drug development and regulatory decision making. The strategic development of multidisciplinary projects aimed at integrating methodologies from different disciplines may bridge between preclinical and clinical drug development as well as between academic curiosity and clinical practice. Herein we review the history and present the state of M&S approaches as well as our vision for future challenges and applications.https://doi.org/10.1002/psp4.12425
collection DOAJ
language English
format Article
sources DOAJ
author Stephan Schmidt
Sarah Kim
Valvanera Vozmediano
Rodrigo Cristofoletti
Almut G. Winterstein
Joshua D. Brown
spellingShingle Stephan Schmidt
Sarah Kim
Valvanera Vozmediano
Rodrigo Cristofoletti
Almut G. Winterstein
Joshua D. Brown
Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
CPT: Pharmacometrics & Systems Pharmacology
author_facet Stephan Schmidt
Sarah Kim
Valvanera Vozmediano
Rodrigo Cristofoletti
Almut G. Winterstein
Joshua D. Brown
author_sort Stephan Schmidt
title Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
title_short Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
title_full Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
title_fullStr Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
title_full_unstemmed Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
title_sort pharmacometrics, physiologically based pharmacokinetics, quantitative systems pharmacology—what's next?—joining mechanistic and epidemiological approaches
publisher Wiley
series CPT: Pharmacometrics & Systems Pharmacology
issn 2163-8306
publishDate 2019-06-01
description The application of modeling and simulation (M&S) tools to biological, physiological, and clinical data has great potential to enhance drug development and regulatory decision making. The strategic development of multidisciplinary projects aimed at integrating methodologies from different disciplines may bridge between preclinical and clinical drug development as well as between academic curiosity and clinical practice. Herein we review the history and present the state of M&S approaches as well as our vision for future challenges and applications.
url https://doi.org/10.1002/psp4.12425
work_keys_str_mv AT stephanschmidt pharmacometricsphysiologicallybasedpharmacokineticsquantitativesystemspharmacologywhatsnextjoiningmechanisticandepidemiologicalapproaches
AT sarahkim pharmacometricsphysiologicallybasedpharmacokineticsquantitativesystemspharmacologywhatsnextjoiningmechanisticandepidemiologicalapproaches
AT valvaneravozmediano pharmacometricsphysiologicallybasedpharmacokineticsquantitativesystemspharmacologywhatsnextjoiningmechanisticandepidemiologicalapproaches
AT rodrigocristofoletti pharmacometricsphysiologicallybasedpharmacokineticsquantitativesystemspharmacologywhatsnextjoiningmechanisticandepidemiologicalapproaches
AT almutgwinterstein pharmacometricsphysiologicallybasedpharmacokineticsquantitativesystemspharmacologywhatsnextjoiningmechanisticandepidemiologicalapproaches
AT joshuadbrown pharmacometricsphysiologicallybasedpharmacokineticsquantitativesystemspharmacologywhatsnextjoiningmechanisticandepidemiologicalapproaches
_version_ 1724742950133432320